We found CTLA-4 expression in primary breast cancer lesions to have potential prognostic value; higher CTLA-4 expression in breast cancer cells was associated with worse prognosis, and higher density of interstitial CTLA-4+ lymphocytes with better prognosis. This evidence concerns the gene CTLA4 and breast carcinoma.